Milestone Scientific (NYSE:MLSS) Shares Down 4.2% – Should You Sell?

Milestone Scientific Inc. (NYSE:MLSS)’s stock price was down 4.2% during trading on Monday. The stock traded as low as $0.3510 and last traded at $0.3620. Approximately 277,374 shares traded hands during trading, a decline of 66% from the average session volume of 816,373 shares. The stock had previously closed at $0.3780.

Wall Street Analyst Weigh In

A number of research firms have weighed in on MLSS. Morgan Stanley set a $1.00 target price on shares of Milestone Scientific in a report on Monday, August 17th. Benchmark reiterated a “speculative buy” rating on shares of Milestone Scientific in a report on Monday, August 17th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $1.00.

Milestone Scientific Price Performance

The stock has a 50-day moving average price of $0.45 and a 200-day moving average price of $0.38. The company has a market capitalization of $34.17 million, a P/E ratio of -5.38 and a beta of 1.13.

Milestone Scientific Company Profile

Milestone Scientific Inc is a medical device company that develops and commercializes computer-controlled drug-delivery systems. Its technology is designed to improve the precision, consistency and comfort of injections by regulating delivery pressure and flow, with applications in dentistry and medical procedures.

The company’s dental product portfolio includes The Wand and STA Single Tooth Anesthesia System, which are intended to deliver local anesthetic for procedures involving individual teeth and surrounding tissue.